Yahoo Finance Marijuana Stocks That Could React To The US Farm Bill
CORAL GABLES, FL / ACCESSWIRE / November 30, 2018 / Marijuana stocks could be getting some much needed attention right now. If memory serves correctly, the current farm bill, the Agricultural Act of 2014, funds farm programs through 2018. On May 18th, 2018 the $867 billion 2018 United States farm bill failed in the House of Representatives with a vote of 198 yea to 213 nay. But a recent interest from new party leaders could give a fresh face to this updated Farm Bill.
Marijuana Stocks In Focus: Premier Health Group Inc. (OTC:PHGRF) (CSE:PHGI), Cronos Group (CRON), Namaste Technologies (NXTTF) (N), and CV Sciences (OTC PINK: CVSI)
U.S. lawmakers have struck a deal in principle on the Farm Bill, the top agriculture lawmakers and senators said on Thursday, capping months of bitter partisan debate over the legislation to fund $867 billion in food and agriculture programs.
"We are pleased to announce that we've reached an agreement in principle on the 2018 Farm Bill," a joint statement from the chairmen and ranking members of Senate and House Agriculture Committees said.
Premier Health Group, Inc. (OTC:PHGRF) (CSE:PHGI) has recently engaged in discussions with Licensed Producers under the Access to Cannabis for Medical Purposes Regulation, other licensed medical cannabis companies and government officials in order to establish a framework for both patient and physician education.
"With over 110,000 active patients in our clinic ecosystem it is important that we provide them with the best possible information that allows them to make informed decisions about their personal and family's health. Providing our family physicians with the appropriate tools and knowledge to prescribe cannabis or with the ability to refer patients to a specialist within our clinics is a key outcome of this initiative," said Dr. Essam Hamza, CEO of Premier.
The Canadian medical cannabis clinic market is estimated to be worth approximately $2.35 billion by 2025. With this in mind, the company said that it expects to provide additional updates on acquisitions in Q4-18 and Q1-19.
"Cannabis clinics fit in perfectly with our existing Telemedicine services and comprehensive app plans. The patient will not only be able to see their family doctor with our app, but also connect with their Cannabis clinic healthcare worker, the education nurse and eventually even the pharmacy or LP that is providing the prescription. This team-based and encompassing approach will provide the best and most convenient care for our patients," said Dr. Hamza in a previous release.
At its center, Premier Health Group, Inc. (OTC:PHGRF) (CSE:PHGI) is focused on developing innovative health care approaches that combine human skill based expertise with emerging technologies and will set the gold standard for services in locations of interest worldwide.
HealthVue, Premier Health's subsidiary, is focused on developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics with telemedicine and artificial intelligence.
For More Information On Premier Health Group, Click Here
Cronos Group (CRON) saw its shares climb once again on Friday.
Last month, Cronos announced it had entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion - Israel Institute of Technology ("Technion") to explore the use of cannabinoids and their role in regulating skin health and skin disorders. The preclinical studies will be conducted by Technion over a three-year period and will focus on three skin conditions: acne, psoriasis and wound healing.
Cronos Group operates two wholly-owned Canadian license holders: Peace Naturals Project Inc., which was the first non-incumbent medical cannabis license granted by Health Canada, and Original BC Ltd., which is based in the Okanagan Valley, British Columbia.
For More Information On Cronos Group, Click Here
Namaste Technologies (OTC PINK: NXTTF) (N) operates a global cannabis e-commerce platform with over 30 websites in 20+ countries under various brands. Namaste's product offering through its subsidiaries includes vaporizers, glassware, accessories, CBD products, and the company will soon be selling medical cannabis in the Canadian market.
On Friday Namaste announced record-breaking sales for the Company across its global online platforms, totaling more than $1.24 million (CAD) through the Black Friday and Cyber Monday holiday shopping weekend. The total reported unaudited sales from Friday, November 22 through Monday, November 26 was approximately $988,361.14.
Sean Dollinger , President, and CEO of Namaste comments: "With an increasingly-diverse product selection, excellent customer service and a peerless user experience, Namaste is pleased to offer its customers improved value year over year. We're excited to continue to grow and expand our offerings and services through 2019 and beyond."
For More Information On Namaste, Click Here
CV Sciences (CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors.
This month CV announced its financial results for the third quarter ended September 30, 2018. These included sales of $13,600,000, an increase of 143% compared to Q3 2017, gross profit of $9,945,000, an increase of 149% compared to Q3 2017, and achieved industry's first hemp extract self-affirmed Generally Recognized as Safe status for its hemp-derived CBD gold extract product line.
For More Information On CV Sciences, Click Here
About marijuanastocks.com
MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), MIDAM VENTURES, LLC and Premier Health Group Inc., Midam was hired for a period from 10/1/2018 - 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. Midam was paid $100,000 (CASH) for & were paid "500,000" shares of restricted common shares. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 Midam plans to sell the "500,000" shares of Premier Health Group Inc. that Midam holds currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.
Contact Information:
SOURCE: MarijuanaStocks.com
